A more affordable, lower-risk polio vaccine is on the horizon, research led by the University of Leeds has found.

Data on the number of cases for these diseases from the pre-vaccine era is hard to come by, and even the case counts are ...

University of Leeds researchers have taken a major step towards producing a more affordable and lower-risk polio vaccine ...

Scientists have developed a vaccine using virus-like particles (VLPs), which mimic the poliovirus but do not contain any genetic material. This removes the risk of infection while still triggering an ...

Since being discovered in the 1950s, experiments on HeLa cells have played a role in developing advances like the polio and COVID-19 vaccines, treatments for cancer, HIV, AIDS, and much more.

We are at a critical time and supporting climate journalism is more important than ever. Science News and our parent organization, the Society for Science, need your help to strengthen ...

In a paper published in Nature Communications, the findings show that VLPs produced in both yeast and insect cells can perform equally or better than the current inactivated polio vaccine (IPV ...

Coverage with measles-mumps-rubella (MMR), diphtheria-tetanus-acellular pertussis (DTaP), polio, and varicella, or chickenpox vaccines, all declined in more than 30 states last year compared with ...

The vaccine is to combine GSK’s injectable polio vaccine (IPV) and Biological E’s pentavalent vaccine for diphtheria, tetanus, whooping cough (whole cell pertussis), hepatitis B, and ...

Pakistan’s first nationwide polio campaign of 2025 launched the first week of February, aiming to vaccinate over 45.4 million children under the age of 5 in 159 of the country's 166 districts.